Guardant Health's Shield blood test for colorectal cancer screening is now covered by TRICARE, providing active duty service ...

The past year has been traumatic for many of the volunteer tech warriors of what was once called the United States Digital ...

Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.

The ROAR trial tested the hypothesis that returning familial hypercholesterolemia-associated genetic results leads to ...

Model was developed from the prostate cancer screening group of the PLCO and validated externally in a VA population ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...

Learn how government tech leaders can harness AI, automation and modern frameworks without inheriting risk in our new ebook, sponsored by Carahsoft. Download now!

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...

Prostate cancer is the second-leading cause of cancer death in American men.About 1 in 8 men will be diagnosed with prostate ...

Falke served in World War II and Korea and won the Distinguished Flying Cross for aerial heroism. But he insisted his ...

What’s more, he explained, several groups have examined existing databases (e.g. Optum, prior clinical trials in IPF, registries) and suggested that metformin therapy in people wiht diabetes with IPF ...

Partnership Leverages Callan JMB's Federal Contract Experience, Cold Chain Infrastructure, and Strategic National Stockpile Relationships to ...